ProShares Ultra NASDAQ Biotechnology
21 hedge funds and large institutions have $4.52M invested in ProShares Ultra NASDAQ Biotechnology in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 7 closing their positions.
Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
4
Closed
7
Calls
$1.3M
Puts
$1.48M
Net Calls
-$184K
Net Calls Change
-$1.57M